{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T08:14:17Z","timestamp":1783671257653,"version":"3.55.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guangdong S&T Program","award":["2025B1111110001"],"award-info":[{"award-number":["2025B1111110001"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFA1104900"],"award-info":[{"award-number":["2022YFA1104900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["92068206"],"award-info":[{"award-number":["92068206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s12015-026-11172-y","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T05:41:04Z","timestamp":1781588464000},"page":"2752-2767","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Next-Generation Hepatocyte Expansion: Bridging Molecular Reprogramming with Multicellular Organoids for Clinical Translation"],"prefix":"10.1007","volume":"22","author":[{"given":"Yiyang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongbo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"3","key":"11172_CR1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.cell.2020.09.012","volume":"183","author":"J Lotto","year":"2020","unstructured":"Lotto, J., Drissler, S., Cullum, R., et al. (2020). Single-cell transcriptomics reveals early emergence of liver parenchymal and non-parenchymal cell lineages. Cell, 183(3), 702-716.e714. https:\/\/doi.org\/10.1016\/j.cell.2020.09.012","journal-title":"Cell"},{"issue":"7","key":"11172_CR2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41575-019-0134-x","volume":"16","author":"S Ben-Moshe","year":"2019","unstructured":"Ben-Moshe, S., & Itzkovitz, S. (2019). Spatial heterogeneity in the mammalian liver. Nature Reviews Gastroenterology & Hepatology, 16(7), 395\u2013410. https:\/\/doi.org\/10.1038\/s41575-019-0134-x","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"21","key":"11172_CR3","doi-asserted-by":"publisher","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","volume":"27","author":"E Trefts","year":"2017","unstructured":"Trefts, E., Gannon, M., & Wasserman, D. H. (2017). The liver. Current Biology, 27(21), R1147-r1151. https:\/\/doi.org\/10.1016\/j.cub.2017.09.019","journal-title":"Current Biology"},{"issue":"17","key":"11172_CR4","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1001\/JAMA.2019.2276","volume":"321","author":"T Wong","year":"2019","unstructured":"Wong, T., Dang, K., Ladhani, S., et al. (2019). Prevalence of Alcoholic Fatty Liver Disease Among Adults in the United States, 2001\u20132016. Journal Of The American Medical Association, 321(17), 1723\u20131725. https:\/\/doi.org\/10.1001\/JAMA.2019.2276","journal-title":"Journal Of The American Medical Association"},{"key":"11172_CR5","doi-asserted-by":"crossref","unstructured":"Kanwal, F., Neuschwander-Tetri, B. A., & Loomba, R. (2024). Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease. Hepatology, 79(5), 1212\u20131219.","DOI":"10.1097\/HEP.0000000000000670"},{"key":"11172_CR6","doi-asserted-by":"publisher","first-page":"1189417","DOI":"10.3389\/fcimb.2023.1189417","volume":"13","author":"J Yang","year":"2023","unstructured":"Yang, J., Wang, D., Li, Y., Wang, H., Wang, Y., et al. (2023). Metabolomics in viral hepatitis: Advances and review. Frontiers in Cellular and Infection Microbiology, 13, 1189417. https:\/\/doi.org\/10.3389\/fcimb.2023.1189417","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"11172_CR7","doi-asserted-by":"crossref","unstructured":"EASL Clinical Practice Guidelines: Drug-induced liver injury : Journal of Hepatology (2019). 70(6):1222-1261. 10.1016\/j.jhep.2019.02.014IF: 33.0 Q1 B1.","DOI":"10.1016\/j.jhep.2019.02.014"},{"issue":"2","key":"11172_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi, H., Asrani, S. K., Arab, J. P., et al. (2023). Global burden of liver disease: 2023 update. Journal Of Hepatology, 79(2), 516\u2013537. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.017","journal-title":"Journal Of Hepatology"},{"issue":"3","key":"11172_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.5582\/bst.2024.01176","volume":"18","author":"Y Sugawara","year":"2024","unstructured":"Sugawara, Y., & Hibi, T. (2024). Recent trends and new developments in liver transplantation. Bioscience Trends, 18(3), 206\u2013211. https:\/\/doi.org\/10.5582\/bst.2024.01176","journal-title":"Bioscience Trends"},{"key":"11172_CR10","doi-asserted-by":"crossref","unstructured":"Dwyer, B. J., Macmillan, M. T., & Brennan, P. N. (2021). Cell therapy for advanced liver diseases: Repair or rebuild. Journal of Hepatology, 74(1), 185\u2013199.","DOI":"10.1016\/j.jhep.2020.09.014"},{"issue":"1","key":"11172_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","volume":"18","author":"GK Michalopoulos","year":"2021","unstructured":"Michalopoulos, G. K., & Bhushan, B. (2021). Liver regeneration: Biological and pathological mechanisms and implications. Nature Reviews Gastroenterology & Hepatology, 18(1), 40\u201355. https:\/\/doi.org\/10.1038\/s41575-020-0342-4","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"11172_CR12","doi-asserted-by":"publisher","first-page":"0043","DOI":"10.34133\/bmr.0043","volume":"28","author":"K Wang","year":"2024","unstructured":"Wang, K., Zhu, Y., Li, M., et al. (2024). Genetically Modified Hepatocytes Targeting Bilirubin and Ammonia Metabolism for the Construction of Bioartificial Liver System. Biomater Res, 28, 0043. https:\/\/doi.org\/10.34133\/bmr.0043","journal-title":"Biomater Res"},{"issue":"6","key":"11172_CR13","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.jhep.2019.01.010","volume":"70","author":"M Barahman","year":"2019","unstructured":"Barahman, M., Zhang, W., Harris, H. Y., et al. (2019). Radiation-primed hepatocyte transplantation in murine monogeneic dyslipidemia normalizes cholesterol and prevents atherosclerosis. Journal of Hepatology, 70(6), 1170\u20131179. https:\/\/doi.org\/10.1016\/j.jhep.2019.01.010","journal-title":"Journal of Hepatology"},{"issue":"5557","key":"11172_CR14","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1126\/science.1068660","volume":"295","author":"AJ Strain","year":"5557","unstructured":"Strain, A. J., & Neuberger, J. M. (5557). A bioartificial liver\u2013state of the art. Science, 295(5557), 1005\u20131009. https:\/\/doi.org\/10.1126\/science.1068660","journal-title":"Science"},{"issue":"10","key":"11172_CR15","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1007\/s00134-022-06802-1","volume":"48","author":"F Saliba","year":"2022","unstructured":"Saliba, F., Ba\u00f1ares, R., Larsen, F. S., et al. (2022). Artificial liver support in patients with liver failure: A modified DELPHI consensus of international experts. Intensive Care Medicine, 48(10), 1352\u20131367. https:\/\/doi.org\/10.1007\/s00134-022-06802-1","journal-title":"Intensive Care Medicine"},{"key":"11172_CR16","doi-asserted-by":"crossref","unstructured":"Lee, C. A., Sinha, S., & Fitzpatrick, E. (2018). Hepatocyte transplantation and advancements in alternative cell sources for liver-based regenerative medicine. Journal of Molecular Medicine(Berlin), 96(6), 469\u2013481.","DOI":"10.1007\/s00109-018-1638-5"},{"issue":"1","key":"11172_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13287-023-03370-z","volume":"14","author":"XH Hu","year":"2023","unstructured":"Hu, X. H., Chen, L., Wu, H., et al. (2023). Cell therapy in end-stage liver disease: Replace and remodel. Stem Cell Research & Therapy, 14(1), 141. https:\/\/doi.org\/10.1186\/s13287-023-03370-z","journal-title":"Stem Cell Research & Therapy"},{"key":"11172_CR18","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1002\/hep.20969","volume":"43","author":"N Fausto","year":"2006","unstructured":"Fausto, N., Campbell, J. S., & Riehle, K. J. (2006). Liver regeneration. Hepatology, 43, S45-53. https:\/\/doi.org\/10.1002\/hep.20969","journal-title":"Hepatology"},{"key":"11172_CR19","doi-asserted-by":"crossref","unstructured":"Rombaut, M., Boeckmans, J., & Rodrigues, R. M. (2021). Direct reprogramming of somatic cells into induced hepatocytes: Cracking the Enigma code. Journal Of Hepatology, 75(3), 690\u2013705.","DOI":"10.1016\/j.jhep.2021.04.048"},{"issue":"6","key":"11172_CR20","doi-asserted-by":"publisher","first-page":"101395","DOI":"10.1016\/j.jcmgh.2024.101395","volume":"18","author":"S Wang","year":"2024","unstructured":"Wang, S., Wang, X., & Wang, Y. (2024). The Progress and Promise of Lineage Reprogramming Strategies for Liver Regeneration. Cell Mol Gastroenterol Hepatol, 18(6), 101395. https:\/\/doi.org\/10.1016\/j.jcmgh.2024.101395","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"11172_CR21","doi-asserted-by":"crossref","unstructured":"Zhao, L., Jin, Y., & Donahue, K. (2019). Tissue Repair in the Mouse Liver Following Acute Carbon Tetrachloride Depends on Injury-Induced Wnt\/\u03b2-Catenin Signaling. Hepatology, 69(6), 2623\u20132635.","DOI":"10.1002\/hep.30563"},{"issue":"5","key":"11172_CR22","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/s41588-024-01709-7","volume":"56","author":"J Xu","year":"2024","unstructured":"Xu, J., Guo, P., Hao, S., et al. (2024). A spatiotemporal atlas of mouse liver homeostasis and regeneration. Nature Genetics, 56(5), 953\u2013969. https:\/\/doi.org\/10.1038\/s41588-024-01709-7","journal-title":"Nature Genetics"},{"issue":"1","key":"11172_CR23","doi-asserted-by":"publisher","first-page":"a007898","DOI":"10.1101\/cshperspect.a007898","volume":"5","author":"JL Stamos","year":"2013","unstructured":"StamosJL, & WeisWI (2013). The \u03b2-catenin destruction complex. Cold Spring Harbor Perspectives In Biology, 5(1), a007898. https:\/\/doi.org\/10.1101\/cshperspect.a007898","journal-title":"Cold Spring Harbor Perspectives In Biology"},{"issue":"7653","key":"11172_CR24","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature22313","volume":"545","author":"KS Yan","year":"7653","unstructured":"Yan, K. S., Janda, C. Y., Chang, J., et al. (7653). Non-equivalence of Wnt and R-spondin ligands during Lgr5(+) intestinal stem-cell self-renewal. Nature, 545(7653), 238\u2013242. https:\/\/doi.org\/10.1038\/nature22313","journal-title":"Nature"},{"issue":"7653","key":"11172_CR25","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nature22306","volume":"545","author":"CY Janda","year":"7653","unstructured":"Janda, C. Y., Dang, L. T., You, C., et al. (7653). Surrogate Wnt agonists that phenocopy canonical Wnt and \u03b2-catenin signalling. Nature, 545(7653), 234\u2013237. https:\/\/doi.org\/10.1038\/nature22306","journal-title":"Nature"},{"key":"11172_CR26","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a007906","author":"KM Cadigan","year":"2012","unstructured":"Cadigan, K. M., & Waterman, M. L. (2012). TCF\/LEFs and Wnt signaling in the nucleus. Cold Spring Harbor Perspectives in Biology. https:\/\/doi.org\/10.1101\/cshperspect.a007906","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"7564","key":"11172_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nature14863","volume":"524","author":"B Wang","year":"2015","unstructured":"Wang, B., Zhao, L., Fish, M., et al. (2015). Self-renewing diploid Axin2(+) cells fuel homeostatic renewal of the liver. Nature, 524(7564), 180\u2013185. https:\/\/doi.org\/10.1038\/nature14863","journal-title":"Nature"},{"issue":"7436","key":"11172_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature11826","volume":"494","author":"M Huch","year":"2013","unstructured":"Huch, M., Dorrell, C., Boj, S. F., et al. (2013). In vitro expansion of single Lgr5\u2009+\u2009liver stem cells induced by Wnt-driven regeneration. Nature, 494(7436), 247\u2013250. https:\/\/doi.org\/10.1038\/nature11826","journal-title":"Nature"},{"issue":"5","key":"11172_CR29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/ncb3337","volume":"18","author":"L Planas-Paz","year":"2016","unstructured":"Planas-Paz, L., Orsini, V., Boulter, L., et al. (2016). The RSPO-LGR4\/5-ZNRF3\/RNF43 module controls liver zonation and size. Nature Cell Biology, 18(5), 467\u2013479. https:\/\/doi.org\/10.1038\/ncb3337","journal-title":"Nature Cell Biology"},{"key":"11172_CR30","doi-asserted-by":"crossref","unstructured":"Fan, F., He, Z., & Kong, L. L. (2016). Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration. Science Translational Medicine, 8(352), 352ra108.","DOI":"10.1126\/scitranslmed.aaf2304"},{"issue":"1","key":"11172_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","volume":"30","author":"Z Meng","year":"2016","unstructured":"Meng, Z., Moroishi, T., & Guan, K. L. (2016). Mechanisms of Hippo pathway regulation. Genes & Development, 30(1), 1\u201317. https:\/\/doi.org\/10.1101\/gad.274027.115","journal-title":"Genes & Development"},{"issue":"1","key":"11172_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.gendis.2019.11.003","volume":"8","author":"MR Zinatizadeh","year":"2021","unstructured":"Zinatizadeh, M. R., Miri, S. R., Zarandi, P. K., et al. (2021). The Hippo tumor suppressor pathway (YAP\/TAZ\/TEAD\/MST\/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis. Genes & Diseases, 8(1), 48\u201360. https:\/\/doi.org\/10.1016\/j.gendis.2019.11.003","journal-title":"Genes & Diseases"},{"issue":"1","key":"11172_CR33","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.1038\/s41467-018-07338-z","volume":"9","author":"YA Lee","year":"2018","unstructured":"Lee, Y. A., Noon, L. A., Akat, K. M., Lee, T.-F., et al. (2018). Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of Yap. Nature Communications, 9(1), 4962, Article 4962. https:\/\/doi.org\/10.1038\/s41467-018-07338-z","journal-title":"Nature Communications"},{"issue":"3","key":"11172_CR34","doi-asserted-by":"publisher","first-page":"108284","DOI":"10.1016\/j.celrep.2020.108284","volume":"33","author":"L He","year":"2020","unstructured":"He, L., Yuan, L., Yu, W., et al. (2020). A regulation loop between YAP and NR4A1 balances cell proliferation and apoptosis. Cell Reports, 33(3), 108284, Article 108284. https:\/\/doi.org\/10.1016\/j.celrep.2020.108284","journal-title":"Cell Reports"},{"issue":"12","key":"11172_CR35","doi-asserted-by":"publisher","first-page":"100905","DOI":"10.1016\/j.jhepr.2023.100905","volume":"5","author":"W Li","year":"2023","unstructured":"Li, W., Wu, Y., Hu, W., et al. (2023). Direct mechanical exposure initiates hepatocyte proliferation. JHEP Rep, 5(12), 100905. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100905","journal-title":"JHEP Rep"},{"key":"11172_CR36","doi-asserted-by":"crossref","unstructured":"Shen, Z., Dai, W., & Guo, Y. (2023). Yes-associated protein promotes the proliferation and differentiation of liver progenitor cells during liver fibrosis. Faseb j, 37(5), e22916.","DOI":"10.1096\/fj.202201919R"},{"issue":"4","key":"11172_CR37","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1152\/physrev.00005.2017","volume":"97","author":"C Siebel","year":"2017","unstructured":"Siebel, C., & Lendahl, U. (2017). Notch signaling in development, tissue homeostasis, and disease. Physiological Reviews, 97(4), 1235\u20131294. https:\/\/doi.org\/10.1152\/physrev.00005.2017","journal-title":"Physiological Reviews"},{"key":"11172_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/biom9100608","author":"JM Adams","year":"2019","unstructured":"Adams, J. M., & Jafar-Nejad, H. (2019). The roles of Notch signaling in liver development and disease. Biomolecules. https:\/\/doi.org\/10.3390\/biom9100608","journal-title":"Biomolecules"},{"key":"11172_CR39","doi-asserted-by":"crossref","unstructured":"Kaylan, K. B., Berg, I. C., Biehl, M. J. (2018). Spatial patterning of liver progenitor cell differentiation mediated by cellular contractility and Notch signaling. Elife, 7.10.7554\/eLife.38536.","DOI":"10.7554\/eLife.38536"},{"issue":"2","key":"11172_CR40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.molmet.2015.11.006","volume":"5","author":"DP Sparling","year":"2016","unstructured":"Sparling, D. P., Yu, J., Kim, K., Kim, K. J., et al. (2016). Adipocyte-specific blockade of gamma-secretase, but not inhibition of Notch activity, reduces adipose insulin sensitivity. Molecular Metabolism, 5(2), 113\u2013121. https:\/\/doi.org\/10.1016\/j.molmet.2015.11.006","journal-title":"Molecular Metabolism"},{"key":"11172_CR41","doi-asserted-by":"crossref","unstructured":"Chen, J., Tschudy-Seney, B., & Ma, X. (2018). Salvianolic Acid B Enhances Hepatic Differentiation of Human Embryonic Stem Cells Through Upregulation of WNT Pathway and Inhibition of Notch Pathway. Stem Cells And Development, 27(4), 252\u2013261.","DOI":"10.1089\/scd.2017.0168"},{"key":"11172_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094712","author":"N Wakabayashi","year":"2024","unstructured":"Wakabayashi, N., Yagishita, Y., Joshi, T., et al. (2024). Dual deletion of Keap1 and Rbpj\u03ba genes in liver leads to hepatomegaly and hypercholesterolemia. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms25094712","journal-title":"International Journal of Molecular Sciences"},{"key":"11172_CR43","doi-asserted-by":"crossref","unstructured":"Minnis-Lyons, S. E., Ferreira-Gonz\u00e1lez, S., Aleksieva, N. (2021). Notch-IGF1 signaling during liver regeneration drives biliary epithelial cell expansion and inhibits hepatocyte differentiation. Sci Signal, 14(688).10.1126\/scisignal.aay9185.","DOI":"10.1126\/scisignal.aay9185"},{"key":"11172_CR44","doi-asserted-by":"crossref","unstructured":"Merrell, A. J., Peng, T., & Li, J. (2021). Dynamic Transcriptional and Epigenetic Changes Drive Cellular Plasticity in the Liver. Hepatology, 74(1), 444\u2013457.","DOI":"10.1002\/hep.31704"},{"key":"11172_CR45","doi-asserted-by":"crossref","unstructured":"Ogoke, O., Yousef, O., & Ott, C. (2021). Modeling Liver Organogenesis by Recreating Three-Dimensional Collective Cell Migration: A Role for TGF\u03b2 Pathway. Frontiers In Bioengineering And Biotechnology, 9, 621286.","DOI":"10.3389\/fbioe.2021.621286"},{"key":"11172_CR46","doi-asserted-by":"crossref","unstructured":"Goulart, E., de Caires-Junior, L. C., & Telles-Silva, K. A. (2019). Adult and iPS-derived non-parenchymal cells regulate liver organoid development through differential modulation of Wnt and TGF-\u03b2. Stem Cell Research & Therapy, 10(1), 258.","DOI":"10.1186\/s13287-019-1367-x"},{"key":"11172_CR47","doi-asserted-by":"crossref","unstructured":"Sun, T., Huang, Z., & Liang, W. C. (2021). TGF\u03b22 and TGF\u03b23 isoforms drive fibrotic disease pathogenesis. Science Translational Medicine, 13(605).","DOI":"10.1126\/scitranslmed.abe0407"},{"key":"11172_CR48","doi-asserted-by":"crossref","unstructured":"Deng, Z., Fan, T., & Xiao, C. (2024). TGF-\u03b2 signaling in health, disease, and therapeutics. Signal Transduct Target Ther, 9(1), 61.","DOI":"10.1038\/s41392-024-01764-w"},{"key":"11172_CR49","doi-asserted-by":"crossref","unstructured":"Wrana, J. L., Attisano, L., & C\u00e1rcamo, J. (1992). TGF beta signals through a heteromeric protein kinase receptor complex. Cell, 71(6), 1003\u20131014.","DOI":"10.1016\/0092-8674(92)90395-S"},{"key":"11172_CR50","doi-asserted-by":"publisher","unstructured":"Bird, T. G., M\u00fcller, M., Boulter, L., et al. (454AD). TGF\u03b2 inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence. Science Translational Medicine. https:\/\/doi.org\/10.1126\/scitranslmed.aan1230","DOI":"10.1126\/scitranslmed.aan1230"},{"key":"11172_CR51","doi-asserted-by":"crossref","unstructured":"Karkampouna, S., Goumans, M. J., & Dijke, T., P (2016). Inhibition of TGF\u03b2 type I receptor activity facilitates liver regeneration upon acute CCl4 intoxication in mice. Archives Of Toxicology, 90(2), 347\u2013357.","DOI":"10.1007\/s00204-014-1436-y"},{"issue":"3","key":"11172_CR52","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.stem.2024.01.013","volume":"31","author":"S Wang","year":"2024","unstructured":"Wang, S., Wang, X., Shan, Y., Wang, Y., et al. (2024). Region-specific cellular and molecular basis of liver regeneration after acute pericentral injury. Cell Stem Cell, 31(3), 341-358.e347. https:\/\/doi.org\/10.1016\/j.stem.2024.01.013","journal-title":"Cell Stem Cell"},{"key":"11172_CR53","doi-asserted-by":"crossref","unstructured":"He, Y., Wang, S., & Liu, S. (2023). MSL1 Promotes Liver Regeneration by Driving Phase Separation of STAT3 and Histone H4 and Enhancing Their Acetylation. Adv Sci (Weinh), 10(23), e2301094.","DOI":"10.1002\/advs.202301094"},{"key":"11172_CR54","doi-asserted-by":"crossref","unstructured":"Nam, D. E., Park, S. J., & Omole, S. (2024). Activated Gab1 drives hepatocyte proliferation and anti-apoptosis in liver fibrosis via potential involvement of the HGF\/c-Met signaling axis. PLoS One, 19(6), e0306345.","DOI":"10.1371\/journal.pone.0306345"},{"key":"11172_CR55","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2025.5483","author":"T Wang","year":"2025","unstructured":"Wang, T., Wang, M., Liu, W., et al. (2025). Intracellular CIRP promotes liver regeneration via STAT3 signaling pathway activation after partial hepatectomy in mice. International Journal of Molecular Medicine. https:\/\/doi.org\/10.3892\/ijmm.2025.5483","journal-title":"International Journal of Molecular Medicine"},{"issue":"1","key":"11172_CR56","doi-asserted-by":"publisher","first-page":"7345","DOI":"10.1038\/s41467-022-35167-8","volume":"13","author":"R Guo","year":"2022","unstructured":"Guo, R., Jiang, M., & Wang, G. (2022). IL-6 supports long-term expansion of hepatocytes in vitro. Nature Communications, 13(1), 7345.","journal-title":"Nature Communications"},{"key":"11172_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08861-y","author":"R Igarashi","year":"2025","unstructured":"Igarashi, R., Oda, M., Okada, R., et al. (2025). Generation of human adult hepatocyte organoids with metabolic functions. Nature. https:\/\/doi.org\/10.1038\/s41586-025-08861-y","journal-title":"Nature"},{"key":"11172_CR58","doi-asserted-by":"crossref","unstructured":"Wege, H., Chui, M. S., & Le, H. T. (2003). In vitro expansion of human hepatocytes is restricted by telomere-dependent replicative aging. Cell Transplantation, 12(8), 897\u2013906.","DOI":"10.3727\/000000003771000138"},{"issue":"3","key":"11172_CR59","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jceh.2014.08.001","volume":"4","author":"S Giri","year":"2014","unstructured":"Giri, S., & Bader, A. (2014). Immortalization of human fetal hepatocyte by ectopic expression of human telomerase reverse transcriptase, human papilloma virus (E7) and simian virus 40 large T (SV40 T) antigen towards bioartificial liver support. Journal of Clinical and Experimental Hepatology, 4(3), 191\u2013201. https:\/\/doi.org\/10.1016\/j.jceh.2014.08.001","journal-title":"Journal of Clinical and Experimental Hepatology"},{"key":"11172_CR60","doi-asserted-by":"crossref","unstructured":"Sainz-Ramos, M., Gallego, I., & Villate-Beitia, I. (2021). How Far Are Non-Viral Vectors to Come of Age and Reach Clinical Translation in Gene Therapy? International Journal Of Molecular Sciences, 22(14).","DOI":"10.3390\/ijms22147545"},{"issue":"5","key":"11172_CR61","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/s0168-8278(00)80299-8","volume":"33","author":"J Cai","year":"2000","unstructured":"Cai, J., Ito, M., & Westerman, K. A. (2000). Construction of a non-tumorigenic rat hepatocyte cell line for transplantation: Reversal of hepatocyte immortalization by site-specific excision of the SV40 T antigen. Journal Of Hepatology, 33(5), 701\u2013708.","journal-title":"Journal Of Hepatology"},{"issue":"12","key":"11172_CR62","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/nbt.3377","volume":"33","author":"G Levy","year":"2015","unstructured":"Levy, G., Bomze, D., & Heinz, S. (2015). Long-term culture and expansion of primary human hepatocytes. Nature Biotechnology, 33(12), 1264\u20131271.","journal-title":"Nature Biotechnology"},{"key":"11172_CR63","doi-asserted-by":"crossref","unstructured":"Watanabe, N., Odagiri, H., & Totsuka, E. (2004). A new method to immortalize primary cultured rat hepatocytes. Transplantation Proceedings, 36(8), 2457\u20132461.","DOI":"10.1016\/j.transproceed.2004.08.030"},{"issue":"1","key":"11172_CR64","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1053\/j.gastro.2011.03.047","volume":"141","author":"H Sirma","year":"2011","unstructured":"Sirma, H., Kumar, M., Meena, J. K., et al. (2011). The promoter of human telomerase reverse transcriptase is activated during liver regeneration and hepatocyte proliferation. Gastroenterology, 141(1), 326\u2013337. https:\/\/doi.org\/10.1053\/j.gastro.2011.03.047","journal-title":"Gastroenterology"},{"issue":"2","key":"11172_CR65","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1053\/gast.2003.50064","volume":"124","author":"H Wege","year":"2003","unstructured":"Wege, H., Le, H. T., Chui, M. S., et al. (2003). Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential. Gastroenterology, 124(2), 432\u2013444. https:\/\/doi.org\/10.1053\/gast.2003.50064","journal-title":"Gastroenterology"},{"key":"11172_CR66","doi-asserted-by":"crossref","unstructured":"Kojima, H., Kaita, K. D., & Xu, Z. (2003). The absence of up-regulation of telomerase activity during regeneration after partial hepatectomy in hepatitis B virus X gene transgenic mice. Journal Of Hepatology, 39(2), 262\u2013268.","DOI":"10.1016\/S0168-8278(03)00215-0"},{"key":"11172_CR67","doi-asserted-by":"crossref","unstructured":"Ramboer, E., De Craene, B., & De Kock, J. (2014). Strategies for immortalization of primary hepatocytes. Journal Of Hepatology, 61(4), 925\u2013943.","DOI":"10.1016\/j.jhep.2014.05.046"},{"issue":"7494","key":"11172_CR68","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nature13020","volume":"508","author":"S Zhu","year":"7494","unstructured":"Zhu, S., Rezvani, M., Harbell, J., et al. (7494). Mouse liver repopulation with hepatocytes generated from human fibroblasts. Nature, 508(7494), 93\u201397. https:\/\/doi.org\/10.1038\/nature13020","journal-title":"Nature"},{"issue":"22","key":"11172_CR69","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.7150\/thno.34520","volume":"9","author":"Z Wang","year":"2019","unstructured":"Wang, Z., Li, W., Jing, H., Li, Q., et al. (2019). Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening. Theranostics, 9(22), 6690\u20136705. https:\/\/doi.org\/10.7150\/thno.34520","journal-title":"Theranostics"},{"key":"11172_CR70","doi-asserted-by":"crossref","unstructured":"Raguram, A., Banskota, S., & Liu, D. R. (2022). Therapeutic in vivo delivery of gene editing agents. Cell, 185(15), 2806\u20132827.","DOI":"10.1016\/j.cell.2022.03.045"},{"issue":"5","key":"11172_CR71","doi-asserted-by":"publisher","first-page":"e1252","DOI":"10.1038\/cddis.2014.230","volume":"5","author":"D Xiang","year":"2014","unstructured":"Xiang, D., Liu, C. C., Wang, M. J., Wang, X., et al. (2014). Non-viral FoxM1 gene delivery to hepatocytes enhances liver repopulation. Cell Death & Disease, 5(5), e1252. https:\/\/doi.org\/10.1038\/cddis.2014.230","journal-title":"Cell Death & Disease"},{"issue":"3","key":"11172_CR72","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.stem.2023.01.009","volume":"30","author":"L Li","year":"2023","unstructured":"Li, L., Cui, L., Lin, P., Li, Y., Li, H., et al. (2023). Kupffer-cell-derived IL-6 is repurposed for hepatocyte dedifferentiation via activating progenitor genes from injury-specific enhancers. Cell Stem Cell, 30(3), 283-299.e289. https:\/\/doi.org\/10.1016\/j.stem.2023.01.009","journal-title":"Cell Stem Cell"},{"issue":"8","key":"11172_CR73","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.cmet.2021.06.005","volume":"33","author":"A Loft","year":"2021","unstructured":"Loft, A., Alfaro, A. J., Schmidt, S. F., et al. (2021). Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication. Cell Metabolism, 33(8), 1685-1700.e1689. https:\/\/doi.org\/10.1016\/j.cmet.2021.06.005","journal-title":"Cell Metabolism"},{"key":"11172_CR74","doi-asserted-by":"crossref","unstructured":"Liu, Y., Zhuo, S., & Zhou, Y. (2022). Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis. Journal Of Hepatology, 76(3), 652\u2013664.","DOI":"10.1016\/j.jhep.2021.11.010"},{"issue":"4","key":"11172_CR75","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.trsl.2014.01.005","volume":"163","author":"SA Mao","year":"2014","unstructured":"Mao, S. A., Glorioso, J. M., & Nyberg, S. L. (2014). Liver regeneration. Translational Research, 163(4), 352\u2013362. https:\/\/doi.org\/10.1016\/j.trsl.2014.01.005","journal-title":"Translational Research"},{"issue":"1","key":"11172_CR76","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.stem.2016.10.007","volume":"20","author":"T Katsuda","year":"2017","unstructured":"Katsuda, T., Kawamata, M., Hagiwara, K., et al. (2017). Conversion of terminally committed hepatocytes to culturable bipotent progenitor cells with regenerative capacity. Cell Stem Cell, 20(1), 41\u201355. https:\/\/doi.org\/10.1016\/j.stem.2016.10.007","journal-title":"Cell Stem Cell"},{"issue":"1","key":"11172_CR77","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jhep.2018.09.007","volume":"70","author":"Y Kim","year":"2019","unstructured":"Kim, Y., Kang, K., & Lee, S. B. (2019). Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells. Journal Of Hepatology, 70(1), 97\u2013107.","journal-title":"Journal Of Hepatology"},{"key":"11172_CR78","doi-asserted-by":"crossref","unstructured":"Zhang, K., Zhang, L., & Liu, W. (2018). In vitro Expansion of Primary Human Hepatocytes with Efficient Liver Repopulation Capacity. Cell Stem Cell, 23(6), 806\u2013819e804.","DOI":"10.1016\/j.stem.2018.10.018"},{"key":"11172_CR79","doi-asserted-by":"crossref","unstructured":"Fu, G. B., Huang, W. J., & Zeng, M. (2019). Expansion and differentiation of human hepatocyte-derived liver progenitor-like cells and their use for the study of hepatotropic pathogens. Cell Research, 29(1), 8\u201322.","DOI":"10.1038\/s41422-018-0103-x"},{"key":"11172_CR80","doi-asserted-by":"crossref","unstructured":"Jiang, M., Guo, R., & Ai, Y. (2023). Small molecule drugs promote repopulation of transplanted hepatocytes by stimulating cell dedifferentiation. JHEP Rep, 5(4), 100670.","DOI":"10.1016\/j.jhepr.2023.100670"},{"key":"11172_CR81","doi-asserted-by":"crossref","unstructured":"Li, G., Zeng, M., & Yan, Z. (2024). HDAC inhibitors support long-term expansion of porcine hepatocytes in vitro. Biomedicine & Pharmacotherapy, 177, 116973.","DOI":"10.1016\/j.biopha.2024.116973"},{"key":"11172_CR82","doi-asserted-by":"crossref","unstructured":"Xie, H., Li, G., & Fu, Y. (2024). A two-step strategy to expand primary human hepatocytes in vitro with efficient metabolic and regenerative capacities. Stem Cell Research & Therapy, 15(1), 281.","DOI":"10.1186\/s13287-024-03911-0"},{"key":"11172_CR83","doi-asserted-by":"crossref","unstructured":"Wu, H., Zhou, X., & Fu, G. B. (2017). Reversible transition between hepatocytes and liver progenitors for in vitro hepatocyte expansion. Cell Research, 27(5), 709\u2013712.","DOI":"10.1038\/cr.2017.47"},{"key":"11172_CR84","doi-asserted-by":"crossref","unstructured":"Huch, M., Gehart, H., & van Boxtel, R. (2015). Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell, 160(1\u20132), 299\u2013312.","DOI":"10.1016\/j.cell.2014.11.050"},{"key":"11172_CR85","doi-asserted-by":"crossref","unstructured":"Lugli, N., Kamileri, I., & Keogh, A. (2016). R-spondin 1 and noggin facilitate expansion of resident stem cells from non-damaged gallbladders. Embo Reports, 17(5), 769\u2013779.","DOI":"10.15252\/embr.201642169"},{"key":"11172_CR86","doi-asserted-by":"crossref","unstructured":"Hu, H., Gehart, H., & Artegiani, B. (2018). Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids. Cell, 175(6), 1591\u20131606.e1519.","DOI":"10.1016\/j.cell.2018.11.013"},{"key":"11172_CR87","doi-asserted-by":"crossref","unstructured":"Peng, W. C., Logan, C. Y., & Fish, M. (2018). Inflammatory Cytokine TNF\u03b1 Promotes the Long-Term Expansion of Primary Hepatocytes in 3D Culture. Cell, 175(6), 1607\u20131619e1615.","DOI":"10.1016\/j.cell.2018.11.012"},{"key":"11172_CR88","doi-asserted-by":"crossref","unstructured":"Fukuda, T., Takayama, K., & Hirata, M. (2017). Isolation and expansion of human pluripotent stem cell-derived hepatic progenitor cells by growth factor defined serum-free culture conditions. Experimental Cell Research, 352(2), 333\u2013345.","DOI":"10.1016\/j.yexcr.2017.02.022"},{"key":"11172_CR89","doi-asserted-by":"crossref","unstructured":"Pan, T., Chen, Y., & Zhuang, Y. (2019). Synergistic modulation of signaling pathways to expand and maintain the bipotency of human hepatoblasts. Stem Cell Research & Therapy, 10(1), 364.","DOI":"10.1186\/s13287-019-1463-y"},{"issue":"12","key":"11172_CR90","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41422-019-0242-8","volume":"29","author":"S Wang","year":"2019","unstructured":"Wang, S., Wang, X., Tan, Z., Wang, Y., et al. (2019). Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury. Cell Research, 29(12), 1009\u20131026. https:\/\/doi.org\/10.1038\/s41422-019-0242-8","journal-title":"Cell Research"},{"key":"11172_CR91","doi-asserted-by":"crossref","unstructured":"Mun, S. J., Ryu, J. S., & Lee, M. O. (2019). Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids. Journal Of Hepatology, 71(5), 970\u2013985.","DOI":"10.1016\/j.jhep.2019.06.030"},{"key":"11172_CR92","doi-asserted-by":"crossref","unstructured":"Zhou, T., Wang, W., & Aimaiti, Y. (2019). Direct and indirect coculture of mouse hepatic progenitor cells with mouse embryonic fibroblasts for the generation of hepatocytes and cholangiocytes. Cytotechnology, 71(1), 267\u2013275.","DOI":"10.1007\/s10616-018-0282-9"},{"key":"11172_CR93","doi-asserted-by":"crossref","unstructured":"Sengupta, S., Johnson, B., & Seirup, M. (2020). Co-culture with mouse embryonic fibroblasts improves maintenance of metabolic function of human small hepatocyte progenitor cells. Current Research in Toxicology, 1, 70\u201384.","DOI":"10.1016\/j.crtox.2020.08.001"},{"key":"11172_CR94","doi-asserted-by":"crossref","unstructured":"Lange, C., Bruns, H., & Kluth, D. (2006). Hepatocytic differentiation of mesenchymal stem cells in cocultures with fetal liver cells. World Journal Of Gastroenterology, 12(15), 2394\u20132397.","DOI":"10.3748\/wjg.v12.i15.2394"},{"issue":"16","key":"11172_CR95","doi-asserted-by":"publisher","first-page":"e36120","DOI":"10.1016\/j.heliyon.2024.e36120","volume":"10","author":"HS Roh","year":"2024","unstructured":"Roh, H. S., Kim, D. E., Kim, G., Kim, J., Kim, H. S., Kim, Y.-H., Kim, B. G., et al. (2024). Establishment and long-term expansion of adult hepatobiliary organoids co-cultured with liver endothelial cells. Heliyon, 10(16), Article e36120. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36120","journal-title":"Heliyon"},{"key":"11172_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08850-1","author":"HA Reza","year":"2025","unstructured":"Reza, H. A., Santangelo, C., Iwasawa, K., Reza, A. A., et al. (2025). Multi-zonal liver organoids from human pluripotent stem cells. Nature. https:\/\/doi.org\/10.1038\/s41586-025-08850-1","journal-title":"Nature"},{"key":"11172_CR97","doi-asserted-by":"crossref","unstructured":"Park, Y., Chen, Y., & Ordovas, L. (2014). Hepatic differentiation of human embryonic stem cells on microcarriers. Journal Of Biotechnology, 174, 39\u201348.","DOI":"10.1016\/j.jbiotec.2014.01.025"},{"issue":"7","key":"11172_CR98","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s10620-019-05925-8","volume":"65","author":"C Gu","year":"2020","unstructured":"Gu, C., Chai, M., Liu, J., et al. (2020). Expansion of transdifferentiated human hepatocytes in a serum-free microcarrier culture system. Digestive Diseases and Sciences, 65(7), 2009\u20132023. https:\/\/doi.org\/10.1007\/s10620-019-05925-8","journal-title":"Digestive Diseases and Sciences"},{"key":"11172_CR99","doi-asserted-by":"crossref","unstructured":"Ye, S., Marsee, A., & van Tienderen, G. S. (2024). Accelerated production of human epithelial organoids in a miniaturized spinning bioreactor. Cell Reports Methods, 4(11), 100903.","DOI":"10.1016\/j.crmeth.2024.100903"},{"issue":"7","key":"11172_CR100","doi-asserted-by":"publisher","first-page":"e70001","DOI":"10.1111\/cpr.70001","volume":"58","author":"H Wu","year":"2025","unstructured":"Wu, H., Wang, J., Liu, S., Wang, Y., Wang, N., et al. (2025). Large-scale production of expandable hepatoblast organoids and polarised hepatocyte organoids from hESCs under 3D static and dynamic suspension conditions. Cell Proliferation, , Article e70001. https:\/\/doi.org\/10.1111\/cpr.70001","journal-title":"Cell Proliferation"},{"key":"11172_CR101","doi-asserted-by":"crossref","unstructured":"Pavlica, S., Piscioneri, A., & Peinemann, F. (2009). Rat embryonic liver cell expansion and differentiation on NH3 plasma-grafted PEEK-WC-PU membranes. Biomaterials, 30(33), 6514\u20136521.","DOI":"10.1016\/j.biomaterials.2009.08.024"},{"key":"11172_CR102","doi-asserted-by":"crossref","unstructured":"Du, Y., Liu, Y., & Hu, J. (2023). CRISPR\/Cas9 systems: Delivery technologies and biomedical applications. Asian Journal Of Pharmaceutical Sciences, 18(6), 100854.","DOI":"10.1016\/j.ajps.2023.100854"},{"key":"11172_CR103","doi-asserted-by":"crossref","unstructured":"Lin, Y. Q., Feng, K. K., & Lu, J. Y. (2023). CRISPR\/Cas9-based application for cancer therapy: Challenges and solutions for non-viral delivery. Journal Of Controlled Release : Official Journal Of The Controlled Release Society, 361, 727\u2013749.","DOI":"10.1016\/j.jconrel.2023.08.028"},{"key":"11172_CR104","doi-asserted-by":"crossref","unstructured":"Zhang, K., Wan, P., & Wang, L. (2024). Efficient expansion and CRISPR-Cas9-mediated gene correction of patient-derived hepatocytes for treatment of inherited liver diseases. Cell Stem Cell, 31(8), 1187\u20131202e1188.","DOI":"10.1016\/j.stem.2024.04.022"},{"key":"11172_CR105","doi-asserted-by":"crossref","unstructured":"Hendriks, D., Artegiani, B., & Hu, H. (2021). Establishment of human fetal hepatocyte organoids and CRISPR-Cas9-based gene knockin and knockout in organoid cultures from human liver. Nature Protocols, 16(1), 182\u2013217.","DOI":"10.1038\/s41596-020-00411-2"},{"key":"11172_CR106","doi-asserted-by":"crossref","unstructured":"Wang, J., Ren, H., & Liu, Y. (2021). Bioinspired Artificial Liver System with hiPSC-Derived Hepatocytes for Acute Liver Failure Treatment. Advanced Healthcare Materials, 10(23), e2101580.","DOI":"10.1002\/adhm.202101580"},{"issue":"16","key":"11172_CR107","doi-asserted-by":"publisher","first-page":"7620","DOI":"10.7150\/thno.58515","volume":"11","author":"J Weng","year":"2021","unstructured":"Weng, J., Han, X., Zeng, F., Zeng, M., et al. (2021). Fiber scaffold bioartificial liver therapy relieves acute liver failure and extrahepatic organ injury in pigs. Theranostics, 11(16), 7620\u20137639. https:\/\/doi.org\/10.7150\/thno.58515","journal-title":"Theranostics"},{"key":"11172_CR108","unstructured":"To investigate the safety and efficacy of HepAssis2\u00ae bioartificial liver in patients with liver failure: a prospective, randomized controlled clinical trial. Chinese Clinical Trial Registry Identifier: ChiCTR2300075781. Chinese Clinical Trial Registry. Updated February 18 (2024). Available from: https:\/\/www.chictr.org.cn\/showproj.html?proj=201606 [Accessed May 5, 2025]."},{"key":"11172_CR109","unstructured":"Randomized, O. L. Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w\/ AILD. ClinicalTrials.gov Identifier: NCT02612428. ClinicalTrials.gov. Updated January 25, 2019. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02612428?term=NCT02612428&rank=1 [Accessed May 5, 2025]."},{"key":"11172_CR110","unstructured":"Study to Evaluate Safety and Efficacy of LifeLiver in Acute or Acute-on-Chronic Liver Failure Patients. ClinicalTrials.gov Identifier: NCT03882346. ClinicalTrials.gov. Updated April 28, 2020. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03882346?term=NCT03882346&rank=1 [Accessed May 5, 2025]."},{"key":"11172_CR111","unstructured":"RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLF. ClinicalTrials.gov Identifier: NCT04195282. ClinicalTrials.gov. Updated December 11, 2019. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04195282?term=NCT04195282&rank=1 [Accessed May 5, 2025]."},{"key":"11172_CR112","unstructured":"The Treatment of Bioartificial Liver With hiHep Cells After Extensive Hepatectomy ClinicalTrials.gov Identifier: NCT05035108. ClinicalTrials.gov. Updated April 13, 2025. Available from: https:\/\/clinicaltrials.gov\/expert-search?term=NCT05035108 [Accessed May 5, 2025]."},{"key":"11172_CR113","unstructured":"Phase, I., & Trial of QH-1A Hybrid Bio-Artificial Liver With Ex Vivo Blood-Purifying MSCs. in Acute-on-Chronic Liver Failure: Safety, Efficacy, and Treatment Schedule Exploration. ClinicalTrials.gov Identifier: NCT06996392. ClinicalTrials.gov. Updated May 30, 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06996392 [Accessed May 8, 2026]."},{"key":"11172_CR114","unstructured":"Clinical research for treatment of liver cirrhosis by human allogeneic hepatic cells. Chinese Clinical Trial Registry. Identifier: ChiCTR2000032383. Chinese Clinical Trial Registry. Updated December 14, 2021. Available from: https:\/\/www.chictr.org.cn\/showproj.html?proj=48805 [Accessed May 5, 2025]."},{"key":"11172_CR115","unstructured":"A Clinical Research on the Safety of Hepatocytes Therapy Generated from Human Embryonic Stem Cells for Patients with Acute or Acute-on-Chronic Liver Failure. Chinese Clinical Trial Registry. Identifier: ChiCTR2100052988. Chinese Clinical Trial Registry. Updated August 31 (2022). Available from: https:\/\/www.chictr.org.cn\/showproj.html?proj=133608 [Accessed May 5, 2025]."},{"key":"11172_CR116","unstructured":"Clinical Study of Hepatocyte Transplantation for Liver Cirrhosis ClinicalTrials.gov Identifier: NCT04806581. ClinicalTrials.gov. Updated March 19, 2021. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04806581?term=NCT04806581&rank=1 [Accessed May 5, 2025]."},{"key":"11172_CR117","unstructured":"Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes. ClinicalTrials.gov Identifier: NCT04496479. ClinicalTrials.gov. Updated September 21 (2023). Available from: https:\/\/clinicaltrials.gov\/study\/NCT04496479?term=NCT04496479&rank=1 [Accessed May 5, 2025]."},{"key":"11172_CR118","unstructured":"Hepatocyte Microbeads for Acute Liver Failure (HELP). ClinicalTrials.gov Identifier: NCT05491135. ClinicalTrials.gov. Updated August 8 (2022). Available from: https:\/\/clinicaltrials.gov\/study\/NCT05491135?term=NCT05491135&rank=1 [Accessed May 5, 2025]."},{"key":"11172_CR119","unstructured":"Micro-encapsulated Hepatocyte Intraperitoneal Transplantation in Liver Failure Adults ClinicalTrials.gov Identifier: NCT05727722. ClinicalTrials.gov. Updated February 14, 2023. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05727722?term=NCT05727722&rank=1 [Accessed May 5, 2025]."},{"issue":"6","key":"11172_CR120","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/00007890-200103270-00020","volume":"71","author":"B Reddy","year":"2001","unstructured":"Reddy, B., Gupta, S., Chuzhin, Y., et al. (2001). The effect of CD28\/B7 blockade on alloreactive T and B cells after liver cell transplantation. Transplantation, 71(6), 801\u2013811. https:\/\/doi.org\/10.1097\/00007890-200103270-00020","journal-title":"Transplantation"},{"issue":"1","key":"11172_CR121","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/00007890-199801150-00010","volume":"65","author":"GL Bumgardner","year":"1998","unstructured":"Bumgardner, G. L., Li, J., Heininger, M., et al. (1998). In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model. Transplantation, 65(1), 47\u201352. https:\/\/doi.org\/10.1097\/00007890-199801150-00010","journal-title":"Transplantation"},{"issue":"3","key":"11172_CR122","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1053\/j.gastro.2020.10.002","volume":"160","author":"T Shinozawa","year":"2021","unstructured":"Shinozawa, T., Kimura, M., Cai, Y., et al. (2021). High-fidelity drug-induced liver injury screen using human pluripotent stem cell-derived organoids. Gastroenterology, 160(3), 831-846.e8. https:\/\/doi.org\/10.1053\/j.gastro.2020.10.002","journal-title":"Gastroenterology"},{"issue":"11","key":"11172_CR123","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/s41587-023-01680-4","volume":"41","author":"D Hendriks","year":"2023","unstructured":"Hendriks, D., Brouwers, J. F., Hamer, K., et al. (2023). Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis. Nature Biotechnology, 41(11), 1567\u20131581. https:\/\/doi.org\/10.1038\/s41587-023-01680-4","journal-title":"Nature Biotechnology"},{"issue":"12","key":"11172_CR124","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier, L., Mastrogiovanni, G., Verstegen, M. M., et al. (2017). Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nature Medicine, 23(12), 1424\u20131435. https:\/\/doi.org\/10.1038\/nm.4438","journal-title":"Nature Medicine"},{"issue":"1","key":"11172_CR125","doi-asserted-by":"publisher","first-page":"22935","DOI":"10.1038\/s41598-023-50250-w","volume":"13","author":"SJ Mun","year":"2023","unstructured":"Mun, S. J., Hong, Y. H., Shin, Y., et al. (2023). Efficient and reproducible generation of human induced pluripotent stem cell-derived expandable liver organoids for disease modeling. Scientific Reports, 13(1), 22935, Article 22935. https:\/\/doi.org\/10.1038\/s41598-023-50250-w","journal-title":"Scientific Reports"},{"issue":"3","key":"11172_CR126","doi-asserted-by":"publisher","first-page":"113918","DOI":"10.1016\/j.celrep.2024.113918","volume":"43","author":"Y Li","year":"2024","unstructured":"Li, Y., Nie, Y., Yang, X., Li, Q., et al. (2024). Integration of Kupffer cells into human iPSC-derived liver organoids for modeling liver dysfunction in sepsis. Cell Reports, 43(3), 113918, Article 113918. https:\/\/doi.org\/10.1016\/j.celrep.2024.113918","journal-title":"Cell Reports"},{"issue":"6531","key":"11172_CR127","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1126\/science.aaz6964","volume":"371","author":"F Sampaziotis","year":"6531","unstructured":"Sampaziotis, F., Muraro, D., Tysoe, O. C., et al. (6531). Cholangiocyte organoids can repair bile ducts after transplantation in the human liver. Science, 371(6531), 839\u2013846. https:\/\/doi.org\/10.1126\/science.aaz6964","journal-title":"Science"},{"issue":"1","key":"11172_CR128","doi-asserted-by":"publisher","first-page":"7424","DOI":"10.1038\/s41467-024-51487-3","volume":"15","author":"E Carolina","year":"2024","unstructured":"Carolina, E., Kuse, Y., Okumura, A., Okumura, T., et al. (2024). Generation of human iPSC-derived 3D bile duct within liver organoid by incorporating human iPSC-derived blood vessel. Nature Communications, 15(1), 7424. https:\/\/doi.org\/10.1038\/s41467-024-51487-3","journal-title":"Nature Communications"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11172-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-026-11172-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11172-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:27:53Z","timestamp":1783668473000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-026-11172-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":128,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["11172"],"URL":"https:\/\/doi.org\/10.1007\/s12015-026-11172-y","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Consent for Publication","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}